The role of myocardial perfusion imaging in patient assessment after acute myocardial infarction
Cardiovascular Division, Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia, U.S.A.
* Correspondence: George A. Beller, MD, Cardiovascular Division, Department of Medicine, University of Virginia Health System, P.OO. Box 800158, Charlottesville, VA 22908-0158, U.S.A.
Abstract
Myocardial perfusion imaging (MPI) is a useful noninvasive test for the evaluation of patients following acute myocardial infarction (AMI). Early (23 days postadmission) pharmacological stress or pre-discharge exercise MPI in patients with uncomplicated AMI is safe and provides important prognostic information of the risk of subsequent cardiac events. The most powerful predictors of prognosis (total defect size, extent of reversibility and resting left ventricular ejection fraction) can be assessed with a single non-invasive test employing gated single photon emission computed tomography (gated-SPECT) technology.
Key Words: Myocardial perfusion imaging acute myocardial infarction risk assessment
References
- Brown KA. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol. 1996;3:516537[CrossRef][Web of Science][Medline]
- Verani MS. Risk stratifying patients who survive an acute myocardial infarction. J Nucl Cardiol. 1998;5:96108[CrossRef][Web of Science][Medline]
- Wackers FJ, Zaret BL. Risk stratification soon after acute infarction. Circulation. 1999;100:20402042
[Free Full Text] - Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. 2000;101:14651478
[Free Full Text] - Shaw LJ, Peterson ED, Kesler K, Hasselblad V, Califf RM. A meta-analysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol. 1996;78:13271337[CrossRef][Web of Science][Medline]
- Gibson RS, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation. 1983;68:321336
[Abstract/Free Full Text] - Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-QWave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 1998;338:17851792
[Abstract/Free Full Text] - Dakik HA, Mahmarian JJ, Kimball KT, Koutelou MG, Medrano R, Verani MS. Prognostic value of exercise 21 'T1 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation. 1996;94:27352742
[Abstract/Free Full Text] - Travin MI, Dessouki A, Cameron T, Heller GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol. 1995;75:665669[CrossRef][Web of Science][Medline]
- Brown KA, Heller GV, Landin RS, et al. Early dipyridamole 99'nTc-sestamibi single photon emission computed tomography imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with sub-maximal exercise imaging. Circulation. 1999;100:20602066
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||